Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years – VISION and IVY Networks, September 2023-January 2024
Related Posts
Makaroff KE, Hawkins A, Chu N, Aw A, Besbris J, Karlin D, Siegel C. Needs-Driven Simulation Education: Advancing Neuropalliative Communication for Neurology Residents. Am J[...]
Kavaliauskas P, Risteen R, Alkhazraji S, Shirtliff B, Walsh TJ, Ibrahim AS, Bruno VM. Integrin ß4 is a receptor for emerging fungal pathogens from the[...]
Barjaktarevic I, Kuhn B, Cooper CB. "The Evolving Science of Ventilation Heterogeneity: From Pathophysiology to Personalized Therapeutic Approaches". Respir Med. 2026 Apr 6:108811. doi: 10.1016/j.rmed.2026.108811.[...]